| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.36 | 0.07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |